Charles River Laboratories (CRL) Stock Analysis: AI Score & Alternative Data
CRL alt-data: job postings climbing, business outlook lagging
Is Charles River Laboratories a buy right now? The alternative data says hold. This CRL stock analysis is built on the 25+ alternative data signals AltIndex tracks on Charles River Laboratories every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 49/100: a Hold. The stock trades at $301.79 with a $15B market cap.
The bullish side of the 90-day ledger: job postings up 8.4% to 310 open roles, and web traffic up 8.3% to 216K monthly visits. The drag: business outlook fell 15.2% — now 28% of employees are positive. That tension is what keeps the score mid-range.
CRL’s broader alt-data profile also covers headcount (14K employees, according to LinkedIn), quarterly revenue ($1.0B), and Facebook followers (23K). Every signal links to its own page with full history, the CRL technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on CRL is just below.
Charles River Laboratories AI Stock Analysis
Charles River Laboratories International, Inc. (NYSE: CRL) is a leading provider of essential products and services to accelerate research and drug development efforts. The company operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support.
Analysis generated October 4, 2026.
Recent Charles River Laboratories Stock Alerts
|
Charles River Laboratories | October 9 Insider Alert: Parisotto Shannon M is selling shares |
|
Charles River Laboratories | October 6 Employee Rating is down by 3.1% over the last month. |
|
Charles River Laboratories | October 6 Price is up by 6.6% in the last 24h. |
|
Charles River Laboratories | October 5 Price is up by 6% in the last 24h. |
Charles River Laboratories Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 216K | 8.3% | |
| Job Posts | 310 | 8.4% | |
| LinkedIn Employees | 14K | 2.2% | |
| Employee Recommend | 49 | 0% | |
| Business Outlook | 28 | 15.2% | |
| Sentiment | 0 | N/A | |
| Reddit Mentions | 0 | 100.0% | |
| X Mentions | 1 | 66.7% | |
| Stocktwits Mentions | 2 | 100.0% | |
| News Mentions | 0 | 100.0% | |
| Stocktwits Subscribers | 930 | 2.1% | |
| 4chan Mentions | 0 | N/A | |
| X Followers | 9K | 0.5% | |
| Instagram Followers | 6K | 1.6% | |
| Youtube Subscribers | 5K | 1.8% | |
| Facebook Followers | 23K | 0% | |
| Facebook Engagement | 197 | 85.8% |
About Charles River Laboratories (CRL)
Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following segments: Research Models & Services, Discovery & Safety Assessment and Manufacturing Support.
| Price | $301.79 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $15B |
| Year Range | $150 – $311 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest Charles River Laboratories News
View more →
Here’s Why This Strategy Decided to Exit Charles River Laboratories (CRL)September 21 - Yahoo Entertainment |
|
 |
Is Wall Street Bullish or Bearish on Charles River Laboratories Stock?August 26 - Biztoc.com |
 |
5 Insightful Analyst Questions From Charles River Laboratories’s Q2 Earnings CallAugust 13 - Biztoc.com |
 |
Charles River Laboratories (CRL) Q2 2026 Earnings Call TranscriptAugust 12 - Biztoc.com |
 |
Charles River Laboratories Earnings Preview: What to ExpectJuly 20 - Biztoc.com |
See Charles River Laboratories’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for CRL, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREECharles River Laboratories Earnings & Financial Performance
View all earnings →Charles River Laboratories Insider Trading Activity
View all →| Parisotto Shannon M filed to sell 4,807 shares at $0.0. Oct 5 '26 |
| Coleman Glenn filed to sell 27,762 shares at $0.0. Sep 30 '26 |
| FOSTER JAMES C filed to sell 31,596 shares at $0.0. Aug 25 '26 |
| Parisotto Shannon M filed to sell 4,807 shares at $0.0. Aug 19 '26 |
| Andrews Nancy C filed to sell 1,438 shares at $0.0. Aug 18 '26 |
Charles River Laboratories Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Jefferson Shreve |
Jun 23, 25 | Sell | $33K+ |
| Jefferson Shreve |
Jun 23, 25 | Buy | $33K+ |
| Rob Bresnahan |
Jun 2, 25 | Sell | $8K+ |
| Rob Bresnahan |
May 8, 25 | Buy | $33K+ |
| Julie Johnson |
Feb 13, 25 | Buy | $8K+ |
Stocks Similar to Charles River Laboratories
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
ExelixisEXEL |
$59.86 1.4% | $15B | 50 |
 |
Jazz PharmaceuticalsJAZZ |
$218.42 1.8% | $14B | 53 |
 |
Intra-Cellular TherapiesITCI |
$131.89 0.0% | $14B | 54 |
 |
Summit TherapeuticsSMMT |
$17.59 2.5% | $14B | 54 |
 |
Corcept TherapeuticsCORT |
$121.19 2.2% | $13B | 53 |
Explore Charles River Laboratories Data
Frequently Asked Questions: Charles River Laboratories (CRL)
Charles River Laboratories has an AltIndex AI Score of 49/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
49/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Charles River Laboratories (CRL) stock is $301.79 with a market cap of $15B.
As of today, Charles River Laboratories’s PE (Price to Earnings) ratio is —.
View the latest Charles River Laboratories insider transactions to see recent buying and selling activity by company executives and directors.
Check the Charles River Laboratories congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The CRL stock price chart above shows Charles River Laboratories’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Charles River Laboratories technical analysis for RSI, moving averages, and more.
See the stocks similar to Charles River Laboratories section on this page for companies in the same industry ranked by market cap and AI Score.
